Patient market research in India
Understanding Patient Experiences in India?
India’s Digital Personal Data Protection Act, 2023 (DPDP Act) sets a clear framework for handling personal data, including sensitive health information. This legislation impacts how patient market research is conducted, emphasizing consent and data security.
Managing this environment requires careful planning and execution from a research partner. We understand the specific requirements for engaging patients while remaining compliant. Global Vox Populi manages patient market research in India under these local data privacy frameworks.
What we research in India
We conduct patient market research in India to answer critical questions about health conditions, treatment journeys, and patient needs.
This includes understanding disease burden, treatment pathway mapping, and assessing unmet patient needs. We also research patient perceptions of specific therapies, brand health among patient communities, and satisfaction with healthcare services.
Our work often covers concept testing for new medical devices or pharmaceutical products. We customize every research scope based on the specific brief.
Why Patient market research fits (or struggles) in India
Patient market research in India can yield rich insights due to the country’s large and diverse patient population. The method reaches patients across various socio-economic strata and disease states.
However, recruitment can be challenging, especially for rare conditions or specific demographic segments. Urban centers offer better access to patients through organized healthcare networks, while reaching rural patients often requires community engagement and local healthcare worker support.
Language diversity is a significant factor; research must accommodate Hindi, English, and numerous regional languages. Culturally, discussing health issues can be sensitive, particularly for chronic or stigmatized conditions.
Where direct patient engagement proves difficult, we might recommend physician or caregiver interviews as a complementary or alternative approach.
How we run Patient market research in India
Our patient market research in India begins with ethical recruitment, often through specialized patient panels, advocacy groups, or hospital networks with appropriate permissions.
We implement rigorous screening to verify medical conditions, treatment status, and demographic criteria. Quality checks include medical record verification (with consent) and recent-participation flags.
Fieldwork formats typically involve in-depth interviews (IDIs), conducted in-person, via phone, or online, depending on patient preference and accessibility. We cover major Indian languages, including Hindi, English, Marathi, Bengali, Tamil, Telugu, Kannada, Malayalam, Gujarati, and Punjabi.
Our moderators possess medical or pharmaceutical backgrounds and are fluent in the required local languages, delivering culturally sensitive dialogue. During fieldwork, we conduct audio checks and regular debriefs with interviewers.
Deliverables include verbatim transcripts, translated summaries, and comprehensive debrief decks. Project management involves a single lead from kickoff to debrief, delivering consistent communication. We also offer in-depth interviews in India for healthcare professionals and caregivers.
Where we field in India
We field patient market research across India, covering major metropolitan areas and extending into Tier-2 and Tier-3 cities. Our reach includes Mumbai, Delhi, Bengaluru, Chennai, Kolkata, Hyderabad, Ahmedabad, and Pune.
Beyond these hubs, we have established networks to access patients in states like Uttar Pradesh, Rajasthan, Madhya Pradesh, and Bihar. Rural patient populations are reached through local healthcare partnerships and community-level engagement strategies, always with ethical approvals.
Language coverage is comprehensive, making sure that patients can participate in their native tongue, from the dominant languages to specific regional dialects where required. This broad geographic and linguistic capability allows us to capture diverse patient experiences across the country.
Methodology, standards, and ethics
We conduct all patient market research adhering to global and local ethical standards.
Our work aligns with ESOMAR principles, the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics (2016 revision), and where applicable, ISO 20252:2019. We also follow guidelines set by the Market Research Society of India (MRSI).
For qualitative patient research, we apply frameworks emphasizing semi-structured guides, empathetic interviewing, and patient-centric approaches.
Applying these standards to patient research means obtaining explicit informed consent from every participant. This consent form details the research purpose, data usage, anonymity measures, and the patient’s right to withdraw at any time.
We deliver full transparency about the research sponsor’s industry (e.g., pharmaceutical, medical device) without revealing their specific name. Data collection and handling prioritize patient anonymity, with all personal identifiers removed or pseudonymized promptly.
Quality assurance protocols are stringent. These include peer review of discussion guides, back-checking recruitment validity, and transcript accuracy checks. For any market research companies in India, maintaining these checks is important.
We also validate quotas to make sure the sample accurately reflects the target patient profile. Our team conducts regular internal reviews of fieldwork progress and data quality, delivering consistency and reliability throughout the project lifecycle.
Drivers and barriers for Patient market research in India
DRIVERS:
- India’s rapidly expanding healthcare sector, driven by medical tourism and increasing health expenditure, fuels demand for patient insights.
- The growing adoption of digital health platforms supports patient engagement and recruitment in some segments.
- A large and diverse patient pool across various therapeutic areas offers rich opportunities for granular understanding.
- Also, a rising awareness of patient rights and advocacy groups contributes to willingness to participate in research.
BARRIERS:
- Language fragmentation across India presents a significant challenge, requiring multi-lingual research teams and materials.
- Recruiting patients with rare diseases or from specific socio-economic backgrounds can be difficult due to access issues and lower incidence rates.
- Cultural sensitivities surrounding specific health conditions or discussing personal medical information can impact participation and candor.
- Additionally, managing the varied ethical review processes across different healthcare institutions can slow project timelines.
- We invite you to share your brief to discuss these factors.
Compliance and data handling under India’s framework
All patient market research conducted by Global Vox Populi in India fully complies with the Digital Personal Data Protection Act, 2023 (DPDP Act).
This includes strict adherence to principles of lawful processing, purpose limitation, and data minimization. We obtain explicit, informed consent from all participants, clearly outlining how their personal and health data will be used and protected.
Data residency requirements are met by processing and storing identifiable data within India where mandated, before anonymization. Patient data is pseudonymized or anonymized as soon as operationally feasible, minimizing privacy risks. We implement reliable security measures to prevent unauthorized access or disclosure.
Patients retain rights to access, correction, and erasure of their personal data, which we support according to the DPDP Act.
Top 20 industries we serve in India
- Pharma & Biotech: Patient journey mapping, unmet needs analysis, treatment adherence studies.
- Healthcare Providers: Patient experience research, hospital choice drivers, service improvement studies.
- Medical Devices: User experience for devices, post-market surveillance insights, product concept testing.
- Health Insurance: Policyholder satisfaction, claims experience research, new product design input.
- Digital Health & Telemedicine: App usability, patient engagement platforms, remote monitoring service evaluation.
- FMCG (Health & Wellness): Consumer perception of health supplements, functional foods, personal care products.
- Public Health & NGOs: Program evaluation, health awareness campaign effectiveness, disease prevention insights.
- Wellness & Nutrition: Dietary habits, supplement usage, lifestyle intervention effectiveness.
- Ayurveda & Traditional Medicine: Patient perceptions of traditional therapies, efficacy beliefs, usage patterns.
- Diagnostics: Patient experience with testing services, perception of diagnostic accuracy.
- Medical Education: Patient and family understanding of conditions, health literacy assessments.
- Biotechnology: Patient attitudes towards novel therapies, genetic testing perceptions.
- Veterinary Pharma: Pet owner perceptions of animal health products, treatment decisions.
- Market Access & Reimbursement: Patient willingness-to-pay, access barriers, advocacy impact.
- Clinical Research Organizations: Patient recruitment barriers, trial participant experience.
- Retail Pharmacy: Patient experience with pharmacy services, medication adherence support.
- Hospitals & Clinics: Service quality perception, patient loyalty drivers, outpatient experience.
- Government Healthcare: Citizen satisfaction with public health initiatives, scheme awareness.
- Medical Tourism: Patient motivations for seeking treatment abroad, service expectations.
- Cosmeceuticals: Consumer perceptions of skin health products, efficacy claims.
Companies and brands in our research universe in India
Research projects we field in India regularly cover the competitive sets of category leaders such as Apollo Hospitals, Dr. Reddy’s Laboratories, Cipla, Sun Pharma, and Fortis Healthcare.
The brands and organizations whose categories shape our research scope in India include Max Healthcare, Zydus Cadila, Lupin, Biocon, and Serum Institute of India.
We also consider players like Tata Motors (in relation to employee healthcare benefits), Reliance Industries (through Jio Health Hub), HDFC Bank (for health insurance offerings), and major FMCG companies like Nestle India and Hindustan Unilever (for health and wellness products).
Further examples include Marico, Flipkart (for online pharmacy services), Amazon India, and Airtel (for digital health initiatives). Our work also extends to evaluating the impact of public sector bodies on patient journeys, alongside other key patient market research in Thailand.
Why teams choose Global Vox Populi for Patient market research in India
Our India desk runs on senior researchers with 15+ years average tenure, bringing deep understanding of the country’s healthcare network.
- Translation and back-translation for patient materials and transcripts are handled in-house by native speakers of Hindi, English, Marathi, and Bengali.
- We provide regular, actionable updates during fieldwork, allowing for timely adjustments and informed decision-making.
- Our ethical recruitment practices prioritize patient welfare and data privacy.
Frequently Asked Questions
Q: What kinds of clients commission patient market research in India?
A: Clients commissioning patient market research typically include pharmaceutical companies, medical device manufacturers, healthcare providers, and health insurance firms. We also work with digital health startups, public health organizations, and government bodies seeking to understand patient needs and experiences across various conditions and demographics.
Q: How do you deliver sample quality for India’s diverse patient population?
A: We deliver sample quality by working with specialized recruitment partners and verified patient panels, applying stringent screening criteria including medical verification where appropriate. Our approach accounts for India’s linguistic, regional, and socio-economic diversity, using stratified sampling to represent relevant patient segments accurately. We also validate patient eligibility during recruitment and prior to interviews.
Q: Which languages do you cover in India for patient research?
A: We cover all major Indian languages for patient research, including Hindi, English, Marathi, Bengali, Tamil, Telugu, Kannada, Malayalam, Gujarati, and Punjabi. Our multi-lingual moderators conduct interviews in the patient’s preferred language, delivering natural conversation and accurate capture of nuances. All materials are translated and back-translated for consistency.
Q: How do you reach hard-to-find patient segments in India?
A: Reaching hard-to-find patient segments in India involves a multi-pronged approach. We work with patient advocacy groups, specialized clinics, and key opinion leaders for referrals, always maintaining ethical guidelines. Using digital outreach through disease-specific forums and targeted social media campaigns (with strict privacy controls) also helps identify and engage low-incidence patient populations.
Q: What is your approach to data privacy compliance under India’s DPDP Act?
A: Our approach to data privacy under India’s DPDP Act involves obtaining explicit consent for data collection and processing, delivering data minimization, and implementing reliable security measures. We anonymize or pseudonymize patient data as quickly as possible and adhere to data residency requirements. Patients are informed of their rights, including data access and withdrawal.
Q: Can you combine patient market research with other methods in India?
A: Yes, we frequently combine patient market research with other methods in India to provide a holistic view. This might involve qualitative patient interviews alongside quantitative surveys of caregivers or healthcare professionals. We also integrate patient insights with secondary data analysis for a more comprehensive understanding of market dynamics and treatment environments.
Q: How do you manage cultural sensitivity in India’s healthcare context?
A: Managing cultural sensitivity in India’s healthcare context is essential. Our moderators receive specific training on local customs, communication styles, and taboos related to health. We design research instruments to be culturally appropriate and make sure discussions are conducted respectfully, building trust with patients. This approach helps elicit candid and accurate responses.
Q: What deliverables do clients receive at the end of a patient market research project in India?
A: Clients receive a comprehensive suite of deliverables, typically including verbatim transcripts (translated if needed), detailed qualitative summaries, and a full debrief deck. The debrief deck presents key findings, patient journey maps, unmet needs, and actionable recommendations. We also provide raw data outputs or coded qualitative data as required for client internal analysis.
Q: How do you handle quality assurance and back-checks for patient interviews?
A: Quality assurance for patient interviews includes rigorous back-checking of participant eligibility and key screening points. Our internal quality team reviews a percentage of interviews for adherence to the discussion guide, interviewer neutrality, and data completeness. Transcripts undergo a meticulous review process for accuracy and consistency before analysis.
Q: Do you have experience with multinational patient tracking studies including India?
A: Yes, we have experience integrating India into multinational patient tracking studies. Our local teams deliver consistent methodology application while adapting for country-specific nuances in recruitment and cultural context. We provide harmonized data outputs that allow for cross-country comparisons, contributing to global understanding of patient trends and brand performance.
When your next research brief involves India, let’s talk through it. Request A Quote or View Case Studies from our work.